News for Healthier Living

UT MD Anderson Shares Latest Research Breakthroughs

* Phase 3 results show promise for new immunotherapy advanced lung cancer * Researchers find new role for B7-H3 in cancer immunity and a combination approach that improved outcomes in preclinical models of prostate cancer * Insights suggest which patients are most likely to benefit from CAR T cell therapy and that many patients with appendix cancer could avoid chemotherapy * Blood tests could monitor bone metastases in patients with medullary thyroid cancer * Scientists make advances in detecting risk of and treatment for immunotherapy-related colitis and treatment-induced lung inflammation

September 25, 2026


October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026

September 25 2026

September 24 2026

September 23 2026

September 22 2026

September 21 2026